Russia’s Vektor COVID-19 vaccine to complete clinical trial in September
The clinical trial of a Russian COVID-19 vaccine being developed by the Siberian Vektor research centre is due to be completed in September, the RIA news agency cited Russia’s healthcare watchdog as saying on Friday.